Celularity
CELU • NASDAQ
Celularity is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Joseph Hariri, with a market cap of $39.2M.
Market Cap$39.2M
Employees225.0
CEORobert Joseph Hariri
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ4 2025
Financials
Celularity FAQ
Common questions about Celularity
Celularity is scheduled to report earnings for Q4 2025 on May 7, 2026.
Celularity has approximately 225 employees.